Iofina Share Discussion Threads

[worraps] 31/5/2013 08:46

Coco....thanks for the chart update and trend intact confirmation. Onwards and UPWARDS it seems!!

[king_roster_iii] 31/5/2013 08:42

I think we'll push on up today. People trying to get in before Maisie dog gets her bone.

[superg1] 31/5/2013 08:17

Lib

Sqm now know IOF are material in relation to new supply, but I doubt they know just how material that will become.

However, they clearly didn't want to talk about it.

[skasher094] 31/5/2013 08:17

As for companies watching boards
Went to a meeting with another company in last
Month and they admitted they avidely follow board on
Their company
Iof have admitted as much themself so can't see their competitor
Not doing so also
On the plus side that doesn't mean they believe everything written!
I think they are monitoring however if they made a successful
Bid now that could drop the price of iodine in itself esspecially
As they could speed up roll out faster

[n3tleylucas] 31/5/2013 08:05

Come back noli, you must answer me, you are one of the few I like on here, and you know why ...

[the librarian] 31/5/2013 08:02

Nice update Coco, thanks for that!

Did I detect a little frustration with SQM unable to identify the opex of it's competitors? I don't believe that statement for a second, it's all out there in results etc; they can't be that blinkered!

As for IOF, apparently they have quite a 'cosy' relationship with SQM, it would be naive to think that they don't know what is going on, but need to wait for delivery on their expectations..... and that is where the BOD has been canny.

As for putting in a bid, SQM have had enough of an outlay this year I would suggest, and maybe they will set aside a t/o budget for next year.. but that will be a case of shutting the stable door after the horse has bolted

[n3tleylucas] 31/5/2013 07:47

noli, you told me IOF didn't need funding.

[noli] 31/5/2013 07:44

Ansana, imho iof are and are not under the radar. My reasoning is that all other companies looking at iof will only see whats in the rns. So small mt and 2 plants up and running so in that context they are in view.

What's not in view is all the ppm they have, contracts signed and speed of rollout, so for that reason they are well under the radar. By the end of this year all will be in view as the rollout continues on its merry way.

[superg1] 31/5/2013 07:37

An

The price doesn't need to go up, the value is hidden in contracts and leases. Any suitor would soon find out if they took a serious interest.



On the SQM replies, I think they have told the Analysts a load of BS on why they will lose some iodine business.

They have said Algorta is the reason. Algorta may contribute some, but they failed to mention Cosayach who got a water permit that allows them to increase production and Sirocco who plan to have 400mt more this year.

The questions was 'who are the new entrants' , none of those are new entrants.


Sure SQM are aware of IOF and know they are producing iodine, they will also know that suddenly IOF are not buying iodine and will have noted the year end results where 1mt per week is suddenly 1mt per day, with many more plants to come.

SQM commented on Iofina in their year end results for 2009,2010 and 2011 as not a material player. 2012, when IOF have started the move, SQM said nothing.

They don't want the market to know.

[engelo] 31/5/2013 07:16

However the SQM share price (NYSE:SQM) may be telling us something.

[n3tleylucas] 31/5/2013 05:23

I am the doubt in your heart. Beat.

[n3tleylucas] 31/5/2013 05:09

silence ...

Watch Kim's bass ... look down





hic!

[warmsun] 31/5/2013 00:08

Yep, agree with most of what you say Ansana....good post!

[n3tleylucas] 31/5/2013 00:04

Nevermind all that, come on SCRUTABLE, we're all ... waiting.

[ansana] 31/5/2013 00:01

Sqm know and choose to bide their time IMO. Reason IOF may take out some of their competitors and they won't be upset by that. Doing this will prove to them that IOF are worth taking over. They think they have time to play the long game. Do they, many companies may be interested in IOF and some with deeper pockets than sqm.

I no longer see IOF as under the radar where I do think they gain at the moment is in the financial press/analysts failing to grasp their true potential, not surprising given that IOF are downplaying everything. So while the competitor can see IOF coming up fast they just aren't sure if the share price is based on real delivery this time round or hype. Io1 isn't doing much and io2 is hardly firing on all cylinders.

I am in the camp of get the share price up and rolling out as quickly as possible in case an offer comes in as early as this year. I really hope it won't and agree with Scrutable that I don't want the company to be taken over. Realistically if a good offer is made n my opinion it will go, £7.50, £10.00 the insti's and many PI's will agree to a t/o. A profit isn't a profit til you take it.

[freshvoice] 30/5/2013 23:56

If we think we have escaped the notice of the Chilean miners then its to be hoped they do not read this BB where it has all been spelt out so clearly.

[urbanyeti] 30/5/2013 23:51

I think SQM are slowly waking up, previously they have claimed to be the lowest cost Iodine producer, now they say they are a low cost producer in the lowest quartile.This still sounds good but having 2nd lowest opex is no good if that is $35 compared to our $10 - $15.

[engelo] 30/5/2013 23:40

superg: thanks for SQM earnings call info. As you say, they are either absolutely clueless about IOF: or maintaining this position publicly. Already looking forward to the next one!

[warmsun] 30/5/2013 23:31

Sg, as I say, I hope I am wrong, but if the sector has overlooked us then the bosses of those companies don't deserve their jobs.....! Better get off my soapbox now.

[warmsun] 30/5/2013 23:12

I am sorry, but any good business will know, or should know, it's competitors....I am finding it almost impossible to believe that SQM do not know more about us than some on here believe.....how long will it keep being said on here that we are 'under the radar'....I don't believe it for a moment.
Just my view.....and will be very happy to be proved wrong.

Ps...has anyone found Maisie yet? :)

[alwilliamson] 30/5/2013 22:53

Super, that's an interesting statement from SQM president. It shows they don't fear any new entrants to market at the moment. They believe any market share taken will be from their higher Opex competitors and not them. They seem more preoccupied with whether current prices are to be maintained. I'm sure they are aware of iof as a new producer but hopefully not the scale and speed we're moving.

[supreme mo] 30/5/2013 22:18

ATS, may well have been at the Black and Blue Bar at Borough Market on Thursday 9th May between 10pm and 12.... :-)

On something totally unrelated to the above, I had a quick look at Jeff Ploen's linkedin page. As you can see he has a good history of extracting value out of companies. I am almost tempted to have a closer look at IBIO:

Over the course of my career I have had an extensive background in numerous private and publicly traded companies.

Here is a brief bio:

Mr. Ploen is a current director of Iofina PLC, High Speed Aggregate Inc., and J Paul Consulting Corp. He was also a former director of Petro Uno LTD, a Canadian oil and gas exploration company that was recently purchased by Renegade Petroleum LTD (RPL.V). As the director of finance at Navidec, Inc., now BPZ, Inc (AMEX: BZP; market capitalization of $470 million), I helped facilitate the merger and the initial financing that brought BPZ public. Mr. Ploen is the former CEO of Tamaron Corp., Paradigm Holdings, Inc., and Tonga Capital Corp., all of which were sold or merged into substantially larger corporations.
Currently I am actively involved in multiple companies, working with many investor networks including stock brokers, hedge funds, angel investors, private equity groups and institutional investors.

One of them is Ibio, Inc.:

(NYSE Amex: IBIO) is a biopharmaceutical company focused on using and promoting the use of its proprietary, non-transgenic plant-based iBioLaunch(TM) technology platform by which targeted proteins can be produced, with core operational focus on biosimilars, biobetters, orphan drugs and vaccine discovery, development, production and licensing. The company is headquartered in Newark, DE.

Specialties:Board Member, Investor, Publically Traded Companies, Microcap Investments, Hedge Funds, Investor Relations, Public Relations, Marketing, and Investor Management